(Q85071118)

English

The anti-tumour activity of allogeneic cytokine-induced killer cells in patients who relapse after allogeneic transplant for haematological malignancies

scientific article published on 10 October 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21986635%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

The anti-tumour activity of allogeneic cytokine-induced killer cells in patients who relapse after allogeneic transplant for haematological malignancies (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21986635%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

William Ying Khee Hwang

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21986635%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Y-C Linn

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21986635%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

M Niam

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21986635%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

S Chu

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21986635%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

A Choong

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21986635%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

H-X Yong

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21986635%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

K-K Heng

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21986635%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Y Loh

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21986635%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Y-T Goh

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21986635%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

G Suck

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21986635%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

M Chan

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21986635%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

M Koh

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21986635%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

10 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21986635%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21986635%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

47

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21986635%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21986635%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

957-966

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21986635%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

https://scigraph.springernature.com/pub.10.1038/bmt.2011.202

0 references

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.202

7 January 2021

based on heuristic

inferred from DOI database lookup

High Response Rate to Donor Lymphocyte Infusion after Allogeneic Stem Cell Transplantation for Indolent Non-Hodgkin Lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.202

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.202

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: predictive factors for response and long-term outcome

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.202

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.202

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.202

7 January 2021

based on heuristic

inferred from DOI database lookup

NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.202

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.202

7 January 2021

based on heuristic

inferred from DOI database lookup

Sensitivity of multidrug-resistant tumor cell lines to immunologic effector cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.202

7 January 2021

based on heuristic

inferred from DOI database lookup

Generation of cytokine-induced killer cells from leukaemic samples with in vitro cytotoxicity against autologous and allogeneic leukaemic blasts

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.202

7 January 2021

based on heuristic

inferred from DOI database lookup

Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.202

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.202

7 January 2021

based on heuristic

inferred from DOI database lookup

Revised response criteria for malignant lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.202

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical scale expansion of cytokine-induced killer cells is feasible from healthy donors and patients with acute and chronic myeloid leukemia at various stages of therapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.202

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.202

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the combination of nelarabine and fludarabine in leukemias: clinical response, pharmacokinetics, and pharmacodynamics in leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.202

7 January 2021

based on heuristic

inferred from DOI database lookup

Fludarabine, cytosine arabinoside, granulocyte-colony stimulating factor with or without idarubicin in the treatment of high risk acute leukaemia or myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.202

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.202

7 January 2021

based on heuristic

inferred from DOI database lookup

Functional characterization of T lymphocytes derived from patients with acute myelogenous leukemia and chemotherapy-induced leukopenia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.202

7 January 2021

based on heuristic

inferred from DOI database lookup

Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.202

7 January 2021

based on heuristic

inferred from DOI database lookup

Engineering hematopoietic grafts: purified allogeneic hematopoietic stem cells plus expanded CD8+ NK-T cells in the treatment of lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.202

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.202

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid and massive expansion of cord blood-derived cytokine-induced killer cells: an innovative proposal for the treatment of leukemia relapse after cord blood transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.202

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistance of pancreatic carcinoma cells is reversed by coculturing NK-like T cells with dendritic cells pulsed with tumor-derived RNA and CA 19-9.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.202

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.202

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokine-induced killer cells targeted by the novel bispecific antibody CD19xCD5 (HD37xT5.16) efficiently lyse B-lymphoma cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.202

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of in vitro migratory properties of anti-CD19 chimeric receptor-redirected CIK cells for their potential use in B-ALL immunotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.202

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of the recognition and functional heterogeneity exhibited by cytokine-induced killer cell subsets against acute myeloid leukaemia target cell

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.202

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced killing of human B-cell lymphoma targets by combined use of cytokine-induced killer cell (CIK) cultures and anti-CD20 antibodies.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.202

7 January 2021

based on heuristic

inferred from DOI database lookup

Toward improved immunocompetence of adoptively transferred CD8+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.202

7 January 2021

based on heuristic

inferred from DOI database lookup

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2011.202

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q85071118&oldid=2074861913"